Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

The Immunobiology of the Interleukin-12 Family: Room for Discovery.

Tait Wojno ED, Hunter CA, Stumhofer JS.

Immunity. 2019 Apr 16;50(4):851-870. doi: 10.1016/j.immuni.2019.03.011. Review.

PMID:
30995503
2.

NK1.1 Expression Defines a Population of CD4+ Effector T Cells Displaying Th1 and Tfh Cell Properties That Support Early Antibody Production During Plasmodium yoelii Infection.

Wikenheiser DJ, Brown SL, Lee J, Stumhofer JS.

Front Immunol. 2018 Oct 15;9:2277. doi: 10.3389/fimmu.2018.02277. eCollection 2018.

3.

IL-17 Promotes Differentiation of Splenic LSK- Lymphoid Progenitors into B Cells following Plasmodium yoelii Infection.

Ghosh D, Brown SL, Stumhofer JS.

J Immunol. 2017 Sep 1;199(5):1783-1795. doi: 10.4049/jimmunol.1601972. Epub 2017 Jul 21.

4.

Preclinical photoacoustic models: application for ultrasensitive single cell malaria diagnosis in large vein and artery.

Menyaev YA, Carey KA, Nedosekin DA, Sarimollaoglu M, Galanzha EI, Stumhofer JS, Zharov VP.

Biomed Opt Express. 2016 Aug 24;7(9):3643-3658. eCollection 2016 Sep 1.

5.

ICOS Co-Stimulation: Friend or Foe?

Wikenheiser DJ, Stumhofer JS.

Front Immunol. 2016 Aug 10;7:304. doi: 10.3389/fimmu.2016.00304. eCollection 2016. Review.

6.

An Atypical Splenic B Cell Progenitor Population Supports Antibody Production during Plasmodium Infection in Mice.

Ghosh D, Wikenheiser DJ, Kennedy B, McGovern KE, Stuart JD, Wilson EH, Stumhofer JS.

J Immunol. 2016 Sep 1;197(5):1788-800. doi: 10.4049/jimmunol.1502199. Epub 2016 Jul 22.

7.

In vivo photoacoustic flow cytometry for early malaria diagnosis.

Cai C, Carey KA, Nedosekin DA, Menyaev YA, Sarimollaoglu M, Galanzha EI, Stumhofer JS, Zharov VP.

Cytometry A. 2016 Jun;89(6):531-42. doi: 10.1002/cyto.a.22854. Epub 2016 Apr 14.

8.

The Costimulatory Molecule ICOS Regulates Host Th1 and Follicular Th Cell Differentiation in Response to Plasmodium chabaudi chabaudi AS Infection.

Wikenheiser DJ, Ghosh D, Kennedy B, Stumhofer JS.

J Immunol. 2016 Jan 15;196(2):778-91. doi: 10.4049/jimmunol.1403206. Epub 2015 Dec 14.

9.

Timed action of IL-27 protects from immunopathology while preserving defense in influenza.

Liu FD, Kenngott EE, Schröter MF, Kühl A, Jennrich S, Watzlawick R, Hoffmann U, Wolff T, Norley S, Scheffold A, Stumhofer JS, Saris CJ, Schwab JM, Hunter CA, Debes GF, Hamann A.

PLoS Pathog. 2014 May 8;10(5):e1004110. doi: 10.1371/journal.ppat.1004110. eCollection 2014 May.

10.

Parasites: what are they good for?

Stumhofer JS, Loke P.

Curr Immunol Rev. 2013 Aug 1;9(3):120-128.

11.

Do you see what I see: Recognition of protozoan parasites by Toll-like receptors.

Ghosh D, Stumhofer JS.

Curr Immunol Rev. 2013 Aug;9(3):129-140.

12.

IL-21 is required for optimal antibody production and T cell responses during chronic Toxoplasma gondii infection.

Stumhofer JS, Silver JS, Hunter CA.

PLoS One. 2013 May 7;8(5):e62889. doi: 10.1371/journal.pone.0062889. Print 2013.

13.

The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology.

Hall AO, Beiting DP, Tato C, John B, Oldenhove G, Lombana CG, Pritchard GH, Silver JS, Bouladoux N, Stumhofer JS, Harris TH, Grainger J, Wojno ED, Wagage S, Roos DS, Scott P, Turka LA, Cherry S, Reiner SL, Cua D, Belkaid Y, Elloso MM, Hunter CA.

Immunity. 2012 Sep 21;37(3):511-23. doi: 10.1016/j.immuni.2012.06.014. Epub 2012 Sep 13.

14.

IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.

Villegas-Mendez A, Greig R, Shaw TN, de Souza JB, Gwyer Findlay E, Stumhofer JS, Hafalla JC, Blount DG, Hunter CA, Riley EM, Couper KN.

J Immunol. 2012 Jul 15;189(2):968-79. doi: 10.4049/jimmunol.1200688. Epub 2012 Jun 20.

15.

A role for IL-27 in limiting T regulatory cell populations.

Wojno ED, Hosken N, Stumhofer JS, O'Hara AC, Mauldin E, Fang Q, Turka LA, Levin SD, Hunter CA.

J Immunol. 2011 Jul 1;187(1):266-73. doi: 10.4049/jimmunol.1004182. Epub 2011 May 27.

16.

IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondii.

Silver JS, Stumhofer JS, Passos S, Ernst M, Hunter CA.

J Immunol. 2011 Jul 1;187(1):350-60. doi: 10.4049/jimmunol.1004144. Epub 2011 May 23.

17.

Effect of cyclosporine, dexamethasone, and human CTLA4-Ig on production of cytokines in lymphocytes of clinically normal cats and cats undergoing renal transplantation.

Aronson LR, Stumhofer JS, Drobatz KJ, Hunter CA.

Am J Vet Res. 2011 Apr;72(4):541-9. doi: 10.2460/ajvr.72.4.541.

PMID:
21453156
18.

A role for IL-27p28 as an antagonist of gp130-mediated signaling.

Stumhofer JS, Tait ED, Quinn WJ 3rd, Hosken N, Spudy B, Goenka R, Fielding CA, O'Hara AC, Chen Y, Jones ML, Saris CJ, Rose-John S, Cua DJ, Jones SA, Elloso MM, Grötzinger J, Cancro MP, Levin SD, Hunter CA.

Nat Immunol. 2010 Dec;11(12):1119-26. doi: 10.1038/ni.1957. Epub 2010 Nov 7.

19.

Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation.

Jones GW, Stumhofer JS, Foster T, Twohig JP, Hertzog P, Topley N, Williams AS, Hunter CA, Jenkins BJ, Wang EC, Jones SA.

FASEB J. 2011 Jan;25(1):409-19. doi: 10.1096/fj.10-166843. Epub 2010 Sep 8.

20.

Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection.

Findlay EG, Greig R, Stumhofer JS, Hafalla JC, de Souza JB, Saris CJ, Hunter CA, Riley EM, Couper KN.

J Immunol. 2010 Aug 15;185(4):2482-92. doi: 10.4049/jimmunol.0904019. Epub 2010 Jul 14.

21.

IL-6 promotes NK cell production of IL-17 during toxoplasmosis.

Passos ST, Silver JS, O'Hara AC, Sehy D, Stumhofer JS, Hunter CA.

J Immunol. 2010 Feb 15;184(4):1776-83. doi: 10.4049/jimmunol.0901843. Epub 2010 Jan 18.

22.

IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection.

Anderson CF, Stumhofer JS, Hunter CA, Sacks D.

J Immunol. 2009 Oct 1;183(7):4619-27. doi: 10.4049/jimmunol.0804024. Epub 2009 Sep 11.

23.

IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells.

Diveu C, McGeachy MJ, Boniface K, Stumhofer JS, Sathe M, Joyce-Shaikh B, Chen Y, Tato CM, McClanahan TK, de Waal Malefyt R, Hunter CA, Cua DJ, Kastelein RA.

J Immunol. 2009 May 1;182(9):5748-56. doi: 10.4049/jimmunol.0801162.

24.

Advances in understanding the anti-inflammatory properties of IL-27.

Stumhofer JS, Hunter CA.

Immunol Lett. 2008 May 15;117(2):123-30. doi: 10.1016/j.imlet.2008.01.011. Epub 2008 Mar 3. Review.

25.

T cell expression of MyD88 is required for resistance to Toxoplasma gondii.

LaRosa DF, Stumhofer JS, Gelman AE, Rahman AH, Taylor DK, Hunter CA, Turka LA.

Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3855-60. doi: 10.1073/pnas.0706663105. Epub 2008 Feb 28.

26.

Negative regulation of Th17 responses.

Stumhofer JS, Silver J, Hunter CA.

Semin Immunol. 2007 Dec;19(6):394-9. doi: 10.1016/j.smim.2007.11.006. Epub 2008 Jan 24. Review.

27.

Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10.

Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, O'Shea JJ, Hunter CA.

Nat Immunol. 2007 Dec;8(12):1363-71. Epub 2007 Nov 11.

PMID:
17994025
28.

Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.

Dzierszinski F, Pepper M, Stumhofer JS, LaRosa DF, Wilson EH, Turka LA, Halonen SK, Hunter CA, Roos DS.

Infect Immun. 2007 Nov;75(11):5200-9. Epub 2007 Sep 10.

29.

Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals.

Villarino AV, Tato CM, Stumhofer JS, Yao Z, Cui YK, Hennighausen L, O'Shea JJ, Hunter CA.

J Exp Med. 2007 Jan 22;204(1):65-71. Epub 2007 Jan 16.

30.

Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system.

Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, Villarino AV, Huang Q, Yoshimura A, Sehy D, Saris CJ, O'Shea JJ, Hennighausen L, Ernst M, Hunter CA.

Nat Immunol. 2006 Sep;7(9):937-45. Epub 2006 Aug 13.

PMID:
16906166
31.

Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.

Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Blumenschein W, Churakovsa T, Low J, Presta L, Hunter CA, Kastelein RA, Cua DJ.

J Clin Invest. 2006 May;116(5):1317-26.

32.

IL-27 limits IL-2 production during Th1 differentiation.

Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, Hunter CA.

J Immunol. 2006 Jan 1;176(1):237-47.

Supplemental Content

Loading ...
Support Center